A Phase II Study of Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy.

Trial Profile

A Phase II Study of Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Nov 2017

At a glance

  • Drugs Cabazitaxel (Primary) ; Pegfilgrastim
  • Indications Urogenital cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2017 Status changed from active, no longer recruiting to completed.
    • 08 Sep 2016 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
    • 08 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top